Potassium bicarbonate does not have a defined pharmacological target in the traditional sense. It acts by neutralizing gastric acid (as an antacid) and by providing potassium and bicarbonate ions for electrolyte balance. Its mechanism of action is primarily chemical rather than receptor-mediated.

The activity of potassium bicarbonate is measured by its acid-neutralizing capacity and its ability to provide potassium and bicarbonate ions. As an antacid, it neutralizes hydrochloric acid in the stomach. As an electrolyte, it helps maintain acid-base balance and potassium levels in the body.

In vivo, potassium bicarbonate is used as an antacid to relieve heartburn and indigestion. It is also used as a potassium supplement and to correct metabolic acidosis. It is absorbed and metabolized to provide bicarbonate buffering capacity and potassium ions.

Cell-free assays are not applicable for this compound in a pharmacological context. Its chemical properties, including acid-neutralizing capacity and solubility, can be measured using standard analytical techniques such as titration and pH measurement.

Cellular assays are not applicable as this compound is not a drug in the traditional sense. In the context of cell culture, potassium bicarbonate can be used as a buffering agent in media. Its effects on cellular function are related to its role as an electrolyte and pH buffer.

In vivo animal studies are not typically conducted for this compound in a pharmacological context. In nutritional or toxicological studies, standard rodent studies could be performed to evaluate its effects on acid-base balance, electrolyte levels, and general toxicity.

Absorption, Distribution and Excretion
Potassium bicarbonate is primarily absorbed in the small intestine, with approximately 90% absorbed via passive diffusion. About 90% of ingested exogenous potassium is excreted in urine, the remaining 10% in feces, and a very small amount in sweat. Excreted potassium can be freely filtered by the glomeruli. Biological Half-Life Some studies indicate that after absorption, most potassium in the body is exchanged rapidly, with a half-life of less than 7 hours.
Potassium bicarbonate is absorbed after oral administration and distributes to the extracellular fluid. It is metabolized to provide bicarbonate buffering capacity, and potassium is excreted primarily by the kidneys. PK parameters are not typically characterized for this compound as it is not a conventional drug.

Potassium bicarbonate is generally recognized as safe (GRAS) for use in food and pharmaceutical applications. At high doses, it can cause gastrointestinal irritation, hyperkalemia, and metabolic alkalosis. Standard toxicological assessments have been conducted to support its use in food and pharmaceutical products.

[1]. The crystal structure of potassium bicarbonate, KHCO3. Acta Crystallographica, 1952, 5(2): 292-292.

Potassium bicarbonate is a potassium salt, a monopotassium salt of carbonic acid. It has bactericidal properties and is used in organic agriculture to control powdery mildew and apple scab. It can be used as a food acidity regulator, leavening agent, buffer, and antifungal pesticide. It is a potassium salt and organic salt containing bicarbonate ions. Potassium bicarbonate is a white crystalline, weakly alkaline substance with a salty taste. It is produced by passing carbon dioxide into an aqueous solution of potassium carbonate. Medically, it is used as an antacid. It is registered with the U.S. Food and Drug Administration (FDA) as a suitable, safe, and effective ingredient in over-the-counter antacids. The FDA classifies potassium bicarbonate as a GRAS (Generally Recognized As Safe) ingredient. See also: Potassium ions (with active moiety). Bicarbonate ions (with active moiety)...see more...

---

Drug Indications
Potassium bicarbonate is used as an antacid, electrolyte supplement, and potassium supplement. It can also be used as an excipient in pharmaceutical preparations. Antacids are medications used to neutralize stomach acid shortly after ingestion; their effects are quickly counteracted by the increased stomach acid secretion stimulated by food. Mechanism of Action Potassium bicarbonate's antacid effect is achieved by increasing the pH of the gastrointestinal tract through neutralization of hydrochloric acid. This increased pH inhibits pepsin activity, an enzyme that exacerbates ulcers in the presence of acid. Pharmacodynamics Potassium is the dominant intracellular cation in most human tissues. Potassium ion concentration is crucial for transmitting nerve impulses in specialized tissues such as the brain, heart, and skeletal muscle, and is also essential for maintaining normal kidney function, acid-base balance, and cellular metabolism. Studies have shown that the use of bicarbonate-containing compounds can lead to the release of carbon dioxide. This effect is one of the problems associated with potassium bicarbonate use, as it can cause belching.
Potassium bicarbonate (molecular formula KHCO3, MW 100.12) is an inorganic compound used as an antacid, electrolyte replenisher, and buffering agent. It is also used in food, agriculture, and pharmaceutical formulations. It is generally recognized as safe for its intended uses.

CHKO3

100.1151

99.956

298-14-6

516893

Typically exists as solid at room temperature

2,17 g/cm3

333.6ºC at 760mmHg

292 °C

NotºConsidered to be a fire hazard

1

3

0

5

33.9

0

[K+].[O-]C(=O)O[H]

TYJJADVDDVDEDZ-UHFFFAOYSA-M

InChI=1S/CH2O3.K/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

potassium;hydrogen carbonate

2934.99.9001

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples

Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

---

Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).

View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10： 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)

---

Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).

View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

---

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

---

 (Please use freshly prepared in vivo formulations for optimal results.)